Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. SILO Pharma Inc. (SILO) Message Board

420 with CNW — New Research Finds Legalization H

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 138
(Total Views: 201)
Posted On: 08/10/2022 5:43:13 PM
Avatar
Posted By: NetworkNewsWire
420 with CNW — New Research Finds Legalization Hasn’t Increased Number of Teens Trying Cannabis

Concerns around how the legalization of marijuana for adult use may prompt an increase in the number of young users have been floated by both parents and health researchers since talks on legalization began a decade ago. Critics against the policy change have even gone as far as to issue warnings with no evidence to back the claims. However, new research has found that the legalization of marijuana does not cause more young individuals to try using the substance.

The study, which was conducted by researchers at Michigan State University, found that legalized marijuana retail sales did not increase the number of underage individuals who consumed cannabis. The researchers cited existing studies on the use of alcohol among the youth to highlight the importance between prevalence and incidence. Research from 2016 and 2018 shows that a big proportion of youth in the United States did not drink alcohol until they could legally. The researchers theorized that the same trend could be true with marijuana.

For their study, the researchers used public data of individuals aged between 12 and 20, then those aged 21 and above, obtained from the National Survey on Drug Use and Health. They analyzed the data using the event study model in an attempt to evaluate the causal effect legalization had on marijuana use. This is in addition to projecting levels of cannabis use if legalization hadn’t been enacted.

They discovered that legalizing adult-use marijuana did increase first-time marijuana consumption — but only among individuals who could use the drug legally once the policy change was enacted. In their report, the researchers noted that they observed no evidence of an increase in use among underage individuals.

The lead author of the study, Barrett Wallace Montgomery, stated that by contrast, the number of individuals aged 21 and above who were trying marijuana for the first time after adult-use legalization could double or triple.

NORML, a marijuana advocacy group, stated in a recent blog post that the study’s findings were consistent with previous research, which had shown that adult-use legalization wasn’t linked to increased access or use among young individuals.

The study was partly funded by the National Institutes of Health and its findings were published in the “PLOS One” journal. The study claims to be the first one designed to assess incidence of use as a result of the legalization of adult-use cannabis. Prior studies have centered on prevalence, trying to measure the effect legalization has had on how much marijuana individuals use or how often they use it.

Marijuana industry actors such as Cannabis Strategic Ventures Inc. (OTC: NUGS) will be pleased to see that independent studies are confirming what they knew all along —rather than increasing underage access, creating legal markets would limit how easy it is for youth to get their hands on marijuana.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer




(0)
(0)




SILO Pharma Inc. (SILO) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us